New Resources - Standard Rotations: Neonatology

  

Neonatal ICU 

 

Section Contributor: Kate Gibbs 

 

Topic Outline: 

  1. Hyperbilirubinemia in the preterm infant 

  1. Hyperbilirubinemia in the Newborn 35 or more weeks of Gestation 

  1. Neonatal Sepsis 

  1. Hospital Discharge of the High-Risk Neonate 

  1. Use of Surfactant 

  1. Neonatology References 

  1. Extreme prematurity outcome data 

  1. Use of Palivizumab for Prevention of RSV 

  1. Neonatal ICU 

 

 

  1. Hyperbilirubinemia in the preterm infant 

 MJ Maisels, JF Watchko, VK Bhutani and DK Stevenson. An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation.  Journal of Perinatology (2012); 32: 660-664 http://www.nature.com/jp/journal/v32/n9/full/jp201257a.html 

 

Brief description of resource:  This article describes consensus based guidelines for the management of hyperbilirubinemia in preterm infants less than 35 weeks gestation.  The article gives recommendations for suggested use of phototherapy and exchange transfusion for a given serum bilirubin based upon gestational age.  (PC1,4,5; MK 1; PBL 3) 

 

  1. Hyperbilirubinemia in the Newborn 35 or more weeks of Gestation 

Subcommittee on Hyperbilirubinemia (AAP). Management of Hyperbilirubinemia in the Newborn Infant 35 or more Weeks of Gestation. Pediatrics 2004; 114: 297  316.  http://pediatrics.aappublications.org/content/114/1/297.full 

 

Brief description of resource:  This clinical practice guideline reviews the evidence based strategies for prevention, evaluation and management of hyperbilirubinemia in infants greater than 35 weeks of gestation.  The article includes age based normograms to assess the risk for developing severe hyperbilirubinemia as well as  age and risk factor based normograms that recommend initiation of phototherapy and exchange transfusion for a given serum bilirubin.  A review of opportunities for prevention as well as risk factors and sequelae of severe hyperbilirubinemia is included.  An update to the policy is also available in Pediatrics 2011; 128: e1046-1052 that reviews the commercially available devices for phototherapy. (PC1,4,5; MK 1; PBL 3)   

 

  1. Neonatal Sepsis 

Richard Polin, MD and the Committee on Fetus and Newborn. Management of Neonates with Suspected or Proven Early-Onset Bacterial Sepsis. Pediatrics 2012; 129: 1006-1015  www.pediatrics.org/cgi/doi/10.1542/peds.2012-0541 

 

Brief description of resource: This clinical report provides guidance regarding the potential risk factors, laboratory evaluation and antibiotic prescription for neonates that are being evaluated for early-onset bacterial sepsis (less than 3 days of age).  (PC1,4,5; MK 1; PBL 3) 

 

  1. Hospital Discharge of the High-Risk Neonate 

Committee on Fetus and Newborn. Pediatrics 2008; 122: 1119-1126Hospital Discharge of the High-Risk Neonate. www.pediatrics.org/content/122/5/1119.full.html 

 

Brief description of resource:  This policy statement gives guidelines for planning the hospital discharge of the high risk neonate including factors to assess both the readiness of infant and family for discharge. (PC1,4,5; MK 1; PBL 3; SBP 1, 3) 

  

  1. Use of Surfactant 

William A Engle and the Committee on Fetus and Newborn. Pediatrics 2008; 121: 419-432  www.pediatrics.org/content/121/2/419.full.html 

 

Brief description of resource:  This clinical report reviews the current guidelines for surfactant therapy for the preterm and term neonate.  Indications for surfactant replacement, types of surfactant preparations and impact on short and long term outcomes are reviewed. (PC1,4,5; MK 1; PBL 3)